Community identification of natural health product-drug interactions

Annals of Pharmacotherapy

Volumn 41, Issue 7-8, 2007, Pages 1124-1129

  Charrois, Theresa L ^a   Hill, Richard L ^b   Vu, Duc ^c   Foster, Brian C ^c   Boon, Heather S ^d   Cramer, Kristie ^a   Vohra, Sunita ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b THERAPEUTIC GOODS ADMINISTRATION   (Australia)

^c HEALTH CANADA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Community pharmacy services; Herbal drug interactions

Indexed keywords

ANTIRETROVIRUS AGENT; BARBITURIC ACID DERIVATIVE; CYCLOSPORIN; ECHINACEA EXTRACT; GARLIC EXTRACT; GINSENG EXTRACT; HYDRASTIS EXTRACT; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; KETOCONAZOLE; NATURAL PRODUCT; ORAL CONTRACEPTIVE AGENT; PLANT EXTRACT; RITONAVIR; SERTRALINE; UNCLASSIFIED DRUG; VALERIAN; WARFARIN;

ARTICLE; CANADA; COMMUNITY CARE; CRANBERRY JUICE; FOOD DRUG INTERACTION; HUMAN; PHARMACEUTICAL CARE; PHARMACIST; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; UNSPECIFIED SIDE EFFECT;

ADULT; BIOLOGICAL PRODUCTS; COMMUNITY PHARMACY SERVICES; FEMALE; HERB-DRUG INTERACTIONS; HUMANS; MALE; MIDDLE AGED; PHARMACISTS;

EID: 34547178811     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H463     Document Type: Article

References (39)

1. Natural Health Products Directorate - Health Canada. Baseline natural health products survey among consumers. Ipsos-Reid, March 2005. www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/pubs/eng_cons_survey_e.pdf (accessed 2006 May 1).
2. Roy-Byrne PP, Bystritsky A, Russo J, Craske MG, Sherbourne CD, Stein MB. Use of herbal medicine in primary care patients with mood and anxiety disorders. Psychosomatics 2005;46:117-22.
3. Quandt SA, Chen H, Grzywacz JG, Bell RA, Lang W, Arcury TA. Use of complementary and alternative medicine by persons with arthritis: results of the National Health Interview Survey. Arthritis Rheum 2005;53:748-55.
4. Alvarez-Requejo A, Carvajal A, Begaud B, Moride Y, Vega T, Arias LH. Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol 1998;54:483-8.
5. Barnes J, Mills SY, Abbot NC, Willoughby M, Ernst E. Different standards for reporting ADRs to herbal medicines and conventional OTC medicines: face-to-face interviews with 515 users of herbal medicines. Br J Clin Pharmacol 1998;45:496-500.
6. Wheaton AG, Blanck HM, Gizlice Z, Reyes M. Medicinal herb use in a population-based survey of adults: prevalence and frequency of use, reasons for use, and use among their children. Ann Epidemiol 2005;15:678-85.
7. Winslow LC, Shapiro H. Physicians want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med 2002;162:1176-81.
8. van Grootheest K, Olsson S, Couper M, de Jong-van den Berg L. Pharmacists' role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf 2004;13:457-64.
9. Dolder C, Lacro J, Dolder N, Gregory P. Pharmacists' use of and attitudes and beliefs about alternative medications. Am J Health Syst Pharm 2003;60:1352-7.
10. Canadian Health Monitor, Survey #16, June-July 1997.
11. Welna EM, Hadsall RS, Schommer JC. Pharmacists' personal use, professional practice behaviors, and perceptions regarding herbal and other natural products. J Am Pharm Assoc 2003;43:602-11.
12. Koh HL, Teo HH, Ng HL. Pharmacists' patterns of use, knowledge, and attitudes toward complementary and alternative medicine. J Altern Complement Med 2003;9:51-63.
13. Howard N, Tsourounis C, Kapusnik-Uner J. Dietary supplement survey of pharmacists: personal and professional practices. J Altern Complement Med 2001;7:667-80.
14. Chang ZG, Kennedy DT, Holdford DA, Small RE. Pharmacists' knowledge and attitudes toward herbal medicine. Ann Pharmacother 2000;34:710-5. DOI 10.1345/aph.19263
15. Kemper KJ, Amata-Kynvi A, Dvorkin L, et al. Herbs and other dietary supplements: healthcare professionals' knowledge, attitudes, and practices. Altern Ther Health Med 2003;9:42-9.
16. Natural Health Products Directorate - Health Canada. Compliance policy for natural health products. March 2005. www.hc-sc.gc.ca/dhp-mps/prodnatur/ index_e.html (accessed 2006 May 1).
17. Dillman DA. Mail and internet surveys: the tailored design method. New York: John Wiley & Sons, 1999.
18. Jiang X, Williams KM, Liauw WS, et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2004;57:592-9.
19. Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000;7:273-82.
20. Ernst E. Herb-drug interactions: potentially important but woefully under-researched. Eur J Clin Pharmacol 2000;56:523-4.
21. Natural Health Products Directorate - Health Canada. About adverse reaction reporting. Updated July 2006. www.hc-sc.gc.ca/dhp-mps/medeff/report- declaration/about-apropos/index_e.html#2 (accessed 2007 May 31).
22. Ernst E. St John's wort supplements endanger the success of organ transplantation. Arch Surg 2002;137:316-9.
23. Furler MD, Einarson TR, Walmsley S, Millson M, Bendayan R. Use of complementary and alternative medicine by HIV-infected outpatients in Ontario, Canada. AIDS Patient Care STDs 2003;17:155-68.
24. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St. John's wort. Lancet 2000;355:547-8.
25. Izzo AA. Drug interactions with St. John's wort (Hypericum perforatum): a review of the clinical evidence. Int J Clin Pharmacol Ther 2004;42:139-48.
26. Springuel P. Potentially harmful drug interaction with St. John's wort and prescription drugs. Can Adverse Reaction News 2000;10:1.
27. Griffiths J, Murty M, Pilon K. Suspected warfarin-cranberry juice interaction. Can Adverse Reaction News 2004;14:2.
28. Sadler C, Charrois TL, Vohra S. Gingko biloba: practical management of adverse effects and drug interactions. CPJ/RPC 2006;139:32-5.
29. Charrois TL, Sandhu G, Vohra S. Black cohosh: practical management of adverse effects and drug interactions. CPJ/RPC 2006;139:33-5.
30. Charrois TL, Hrudey J, Vohra S. Ginseng: practical management of adverse effects and drug interactions. CPJ/RPC 2006;139:44-6.
31. Cramer K, Charrois TL, Vohra S. Valerian: practical management of adverse effects and drug interactions. CPJ/RPC 2006;139:39-41.
32. Laeeque H, Charrois TL, Vohra S. Adverse effects and drug interactions relating to the use of St. John's wort. CPJ/RPC 2006;139:30-3.
33. Shamseer L, Charrois TL, Vohra S. Chamomile: practical management of adverse effects and drug interactions. CPJ/RPC 2006;139:32-3.
34. Vohra S, Charrois TL. Addressing adverse effects in natural health products. CPJ/RPC 2006;139:30-1.
35. Health Canada. Health Canada International Symposium on Food, Nutrient, Natural Health Product-Drug Interactions, February 2006. www.hc-sc.gc.ca/dhp- mps/alt_formats/hpfb-dgpsa/pdf/prodpharma/notice_avis_interactions_symposium_e. pdf. (accessed 2006 May 1).
36. Brown CM, Barner JC, Shah S. Community pharmacists' actions when patients use complementary and alternative therapies with medications. J Am Pharm Assoc 2005;45:41-7.
37. ICH Harmonised Tripartite Guideline. Pharmacovigilance Planning, November 2004. www.ich.org/LOB/media/MEDIA1195.pdf (accessed 2006 May 1).
38. Marketed Health Products Directorate. Draft consensus guidelines, pharmacovigilance planning. www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/e2d_step2_3.pdf. Updated November 2003 (accessed 2006 May 1).
39. Alberta College of Pharmacists. Annual Report 2004-2005. www.altapharm.org/document_library/Annualreport20042005.pdf (accessed 2006 April 30).